Ross L. Prentice
University of Washington
Publications 455
#1Haoyu Zhang (Johns Hopkins University)H-Index: 2
#2Thomas U. Ahearn (NIH: National Institutes of Health)H-Index: 11
Last.Manjeet K. Bolla (University of Cambridge)H-Index: 27
view all 10 authors...
Breast cancer susceptibility variants frequently show heterogeneity in associations by tumor subtype. To identify novel loci, we performed a genome-wide association study (GWAS) including 133,384 breast cancer cases and 113,789 controls, plus 18,908 BRCA1 mutation carriers (9,414 with breast cancer) of European ancestry, using both standard and novel methodologies that account for underlying tumor heterogeneity by estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth fac...
#1JoAnn E. Manson (Brigham and Women's Hospital)H-Index: 232
#2Aaron K. Aragaki (Fred Hutchinson Cancer Research Center)H-Index: 43
Last.Andrew M. Kaunitz (UF: University of Florida)H-Index: 45
view all 10 authors...
#1Anouar Fanidi (University of Cambridge)H-Index: 9
#2Anouar Fanidi (University of Cambridge)
Last.Mary Pettinger (Fred Hutchinson Cancer Research Center)H-Index: 44
view all 10 authors...
Vitamin B supplementation can have side effects for human health, including cancer risk. We aimed to elucidate the role of vitamin B12 in lung cancer etiology via direct measurements of pre-diagnostic circulating vitamin B12 concentrations in a nested case–control study, complemented with a Mendelian randomization (MR) approach in an independent case–control sample. We used pre-diagnostic biomarker data from 5183 case–control pairs nested within 20 prospective cohorts, and genetic data from 29,2...
#1Ross L. Prentice (Fred Hutchinson Cancer Research Center)H-Index: 90
#2Aaron K. Aragaki (Fred Hutchinson Cancer Research Center)H-Index: 43
Last.Lewis E Kuller (University of Pittsburgh)
view all 10 authors...
#1Padma Maruvada (NIH: National Institutes of Health)H-Index: 17
#2Johanna W. Lampe (UW: University of Washington)H-Index: 51
Last.John Draper (Aberystwyth University)H-Index: 29
view all 10 authors...
#1Laura D Carbone (Georgia Regents University)H-Index: 30
#2S. Vasan (Fred Hutchinson Cancer Research Center)
Last.Karen C. Johnson (UTHSC: University of Tennessee Health Science Center)H-Index: 68
view all 7 authors...
Summary New users of RAAS inhibitors, including ACE inhibitors and ARBs, have a small increased risk for fracture in the first 3 years of use, with a reduced risk of fracture with longer duration of use.
Background: In addition to the established association between general obesity and breast cancer risk, central obesity and circulating fasting insulin and glucose have been linked to the development of this common malignancy. Findings from previous studies, however, have been inconsistent, and the nature of the associations is unclear. Methods: We conducted Mendelian randomization analyses to evaluate the association of breast cancer risk, using genetic instruments, with fasting insulin, fasting...